Serotonin1B Receptor Stimulation Enhances Cocaine Reinforcement
Overview
Authors
Affiliations
The effects of serotonin1B [5-hydroxytryptamine1B (5-HT1B)] receptor activation on cocaine reinforcement were investigated using intravenous cocaine self-administration by rats. The 5-HT1B receptor agonists 5-methoxy-3-1,2,3,6-tetrahydro-4-pyridinyl-1H-indole (RU 24969) (0.3-3 mg/kg), 3-(1,2,5, 6-tetrahydro-4-pyridyl)-5-propoxypyrrolo[3,2-b]pyridine (CP 94,253) (0.3-3 mg/kg), and 3-(1,2,5,6-tetrahydropyrid-4-yl)pyrrolo[3, 2-b]pyridine (CP 93,129) (3 and 10 micrograms, i.c.v.) each dose-dependently reduced the self-administration of a cocaine dose on the descending limb of the fixed-ratio 5 (FR-5) cocaine dose-effect function, in a manner similar to the effect produced by increasing the unit dose of cocaine. In addition, each of these 5-HT1B agonists lowered the threshold dose of cocaine that supported self-administration. These results are consistent with a 5-HT1B agonist-induced potentiation of cocaine reinforcement. On a progressive ratio schedule of reinforcement, RU 24969 and CP 94,253 dose-dependently (0.3-3 mg/kg) increased the highest completed ratio for cocaine self-administration, again by producing behavioral alterations similar to those induced by increasing the unit dose of cocaine. The effect of CP 94,253 was dose-dependently blocked by the 5-HT1B/1D receptor partial agonist 2'-methyl-4'-(5-methyl[1,2, 4]oxadiazol-3-yl)-biphenyl-4-carboxylic acid[4-methodoxy-3-(4-methyl-piperazin-1-yl)-phenyl]-amide (GR 127, 935) (0.3-10 mg/kg) but was unaffected by the 5-HT1A receptor antagonist 4-iodo-N-[2-[4-(methoxyphenyl)-1-piperazinyl]ethyl]-N-2-pyridinyl- benzamide (p-MPPI; 1-10 mg/kg). Self-administration behavior was not maintained when either RU 24969 or CP 94,253 was substituted for cocaine, indicating that these 5-HT1B agonists do not produce significant reinforcing effects alone. Together, these findings indicate that 5-HT1B receptor stimulation facilitates the reinforcing properties of cocaine. These results are in opposition to recent findings with 5-HT1B receptor knock-out mice and may have important ontogenic implications in the area of drug abuse research.
Piras G, Cadoni C, Caria F, Pintori N, Spano E, Vanejevs M Int J Neuropsychopharmacol. 2024; 27(5).
PMID: 38546531 PMC: 11120233. DOI: 10.1093/ijnp/pyae016.
The role of serotoninergic system in psychostimulant effects.
Taracha E Postep Psychiatr Neurol. 2023; 30(4):258-269.
PMID: 37082555 PMC: 9881639. DOI: 10.5114/ppn.2021.111939.
Scott S, Ruscitti B, Garcia R, Nguyen T, Blattner K, Blass B Front Behav Neurosci. 2022; 16:1020146.
PMID: 36386780 PMC: 9663667. DOI: 10.3389/fnbeh.2022.1020146.
Garcia R, Le T, Scott S, Charmchi D, Sprout J, Pentkowski N Transl Psychiatry. 2020; 10(1):266.
PMID: 32747623 PMC: 7398918. DOI: 10.1038/s41398-020-00956-6.
Miszkiel J, Jastrzebska J, Filip M, Przegalinski E Neurotox Res. 2018; 35(1):217-229.
PMID: 30168018 PMC: 6313351. DOI: 10.1007/s12640-018-9950-y.